• Explore /
  • Poster
  • / CYCLONE 2: A phase II, randomized, placebo-controlled study of abiraterone acetate plus prednisone with or without abemaciclib in patients with metastatic castration-resistant prostate cancer.

CYCLONE 2: A phase II, randomized, placebo-controlled study of abiraterone acetate plus prednisone with or without abemaciclib in patients with metastatic castration-resistant prostate cancer.

Abstract Poster

Authors

null

Matthew Raymond Smith

Massachusetts General Hospital Cancer Center, Boston, MA

Matthew Raymond Smith , Neeraj Agarwal , Tilman Todenhöfer , Redas Trepiakas , Jae-Lyun Lee , Andrew Lithio , Sonya Chapman , Karim Nacerddine , Christopher Sweeney

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT03706365

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS5591)

DOI

10.1200/JCO.2020.38.15_suppl.TPS5591

Abstract #

TPS5591

Poster Bd #

172

Abstract Disclosures

Similar Posters

First Author: Matthew Raymond Smith

First Author: Dana E. Rathkopf

First Author: Neeraj Agarwal

First Author: Christos Kyriakopoulos